AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimixia-M2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Wings Biotech Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimixia-M2 Tablet ER

Diabex Duo ER tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo ER should be taken with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications like kidney damage, vision loss, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying a fast-acting glucose source (e.g., sugary sweets or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before starting this medication. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is vital, and your doctor may order blood tests to check blood cell counts and liver function.

Primary Ingredients of Glimixia-M2 Tablet ER

The provided text is "undefined," which cannot be rephrased while maintaining meaning and length. There is no text to rewrite.

Uses of Glimixia-M2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimixia-M2 Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimixia-M2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Glimixia-M2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimixia-M2 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimixia-M2 Tablet ER whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Glimixia-M2 Tablet ER works:

Glimixia-M2 Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glimixia-M2 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimixia-M2 tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimixia-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimixia-M2 Tablet ER cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimixia-M2 Tablet ER is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimixia-M2 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate Glimixia-M2 Tablet ER therapy at a reduced dosage; its administration is contraindicated in those with severe liver disease.

What if you forget to take Glimixia-M2 Tablet ER :

Should you forget a dose of Glimixia-M2 Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimixia-M2 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimixia-M2 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimixia-M2 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Glimixia-M2 Tablet ER, if you experience these symptoms.
Glimixia-M2 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glimixia-M2 ER is not suitable for treating type 1 DM.
Glimixia-M2 Tablet ER may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimixia-M2 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some studies.
Glimixia-M2 ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimixia-M2 Tablet ER and alcohol is unsafe. Alcohol can heighten the risk of dangerously low blood sugar (hypoglycemia) and lactic acidosis.
Glimixia-M2 Tablet ER
75
MRP 87
13% off